Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy.
Frustaci
A
A
Department of Cardiology, Università Cattolica del Sacro Cuore, Rome.
Chimenti
C
C
Ricci
R
R
Natale
L
L
Russo
M A
MA
Pieroni
M
M
Eng
C M
CM
Desnick
R J
RJ
D002302:Cardiac Output / Q000187:drug effects; D002312:Cardiomyopathy, Hypertrophic / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D004452:Echocardiography; D000795:Fabry Disease / Q000150:complications / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D005690:Galactose / Q000494:pharmacology / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D018832:Molecular Chaperones / Q000502:physiology; D020125:Mutation, Missense; D009206:Myocardium / Q000473:pathology / Q000648:ultrastructure; D000519:alpha-Galactosidase / Q000502:physiology
D018832:Molecular Chaperones; D000519:alpha-Galactosidase; D005690:Galactose